Health knowledge made personal
Join this community!
› Share page:
Search posts:

Europe Gets Dual Auto-immune Approvals

Posted Oct 06 2009 10:01pm
The European Commission issued a pair of approvals for auto-immune conditions.

UCB nailed approval for Cimzia (certolizumab pegol), used for the treatment of patients with rheumatoid arthritis that have failed DMARDs and traditional therapy. Another option is always a good thing. (Ref: UCB press release )

Following closely, J&J (dba Centocor Ortho Biotech) and Schering-Plough (soon to be Merck) received approval for Simponi (golimumab) for the approval of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. (Ref: AP )
Copyright 2007-2009 Pharm Aid. Original source is
Post a comment
Write a comment:

Related Searches